In this issue
Explore the latest AMJ Rheumatology issue with American College of Rheumatology (ACR) Convergence 2025 highlights including the use of GLP-1 agonists in rheumatic diseases and emerging CAR-T targets in lupus. Abstract reviews examine financial toxicity, immunotherapy-related arthritis, vaccine responses, and social media use, alongside leadership interviews and a striking ANCA case report for everyday clinical practice.
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles



We’ve noticed you’re accessing
from North/South America.
from North/South America.